These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28834146)

  • 1. Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta-analysis of a complex issue.
    Zhao C; Jin M; Le RH; Le MH; Chen VL; Jin M; Wong GL; Wong VW; Lim YS; Chuang WL; Yu ML; Nguyen MH
    Liver Int; 2018 Mar; 38(3):503-514. PubMed ID: 28834146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing burden of advanced hepatocellular carcinoma in New Zealand-the need for better surveillance.
    Schauer C; Mules T; Rijnsoever MV; Gane E
    N Z Med J; 2020 May; 133(1515):25-34. PubMed ID: 32438374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting.
    Wong CR; Garcia RT; Trinh HN; Lam KD; Ha NB; Nguyen HA; Nguyen KK; Levitt BS; Nguyen MH
    Dig Dis Sci; 2009 Dec; 54(12):2712-21. PubMed ID: 19876735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B.
    Wang C; Chen V; Vu V; Le A; Nguyen L; Zhao C; Wong CR; Nguyen N; Li J; Zhang J; Trinh H; Nguyen MH
    Medicine (Baltimore); 2016 Aug; 95(35):e4744. PubMed ID: 27583921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.
    Singal AG; Pillai A; Tiro J
    PLoS Med; 2014 Apr; 11(4):e1001624. PubMed ID: 24691105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
    Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
    J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Cirrhosis on Short-term and Long-term Survival of Patients With Hepatitis B-related Hepatocellular Carcinoma.
    Chen VL; Le AK; Kim NG; Kim LH; Nguyen NH; Nguyen PP; Zhao C; Nguyen MH
    Clin Gastroenterol Hepatol; 2016 Jun; 14(6):887-895.e1. PubMed ID: 26820401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.
    Singal AG; Tiro J; Li X; Adams-Huet B; Chubak J
    J Clin Gastroenterol; 2017 Aug; 51(7):650-655. PubMed ID: 27870642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
    Tavakoli H; Robinson A; Liu B; Bhuket T; Younossi Z; Saab S; Ahmed A; Wong RJ
    Dig Dis Sci; 2017 Aug; 62(8):2174-2181. PubMed ID: 28474143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course of sub-centimeter-sized nodules detected during surveillance for hepatocellular carcinoma.
    Min YW; Gwak GY; Lee MW; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    World J Gastroenterol; 2012 Jun; 18(21):2654-60. PubMed ID: 22690074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
    J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study.
    Thein HH; Campitelli MA; Yeung LT; Zaheen A; Yoshida EM; Earle CC
    PLoS One; 2015; 10(9):e0138907. PubMed ID: 26398404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
    El-Serag HB; Kramer JR; Chen GJ; Duan Z; Richardson PA; Davila JA
    Gut; 2011 Jul; 60(7):992-7. PubMed ID: 21257990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis.
    Willemse S; Smit C; Sogni P; Sarcletti M; Uberti-Foppa C; Wittkop L; Raben D; D'Arminio Monforte A; Dabis F; Van Der Valk M;
    J Viral Hepat; 2019 Oct; 26(10):1224-1228. PubMed ID: 31136059
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma surveillance rates in commercially insured patients with noncirrhotic chronic hepatitis B.
    Goldberg DS; Valderrama A; Kamalakar R; Sansgiry SS; Babajanyan S; Lewis JD
    J Viral Hepat; 2015 Sep; 22(9):727-36. PubMed ID: 25581816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
    Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
    Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis.
    Kuo YH; Lu SN; Chen CL; Cheng YF; Lin CY; Hung CH; Chen CH; Changchien CS; Hsu HC; Hu TH; Lee CM; Wang JH
    Eur J Cancer; 2010 Mar; 46(4):744-51. PubMed ID: 20060710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.